Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial

BACKGROUND: Much attention has been drawn to the deleterious effects of adding progestins to estrogen as hormone therapy (HT) in postmenopausal women. Some widely prescribed progestins have been shown to partially oppose the beneficial effects of estrogens on surrogate markers of cardiovascular dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Casanova, Gislaine, Spritzer, Poli Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508911/
https://www.ncbi.nlm.nih.gov/pubmed/23046709
http://dx.doi.org/10.1186/1476-511X-11-133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508911/
https://www.ncbi.nlm.nih.gov/pubmed/23046709
http://dx.doi.org/10.1186/1476-511X-11-133

Ejemplares similares